| Primary |
| Drug Use For Unknown Indication |
31.4% |
| Product Used For Unknown Indication |
15.7% |
| Fungal Infection |
10.0% |
| Dermatitis |
7.1% |
| Ill-defined Disorder |
4.3% |
| Rash |
4.3% |
| Atrial Fibrillation |
2.9% |
| Body Tinea |
2.9% |
| Bronchitis |
2.9% |
| Diabetes Mellitus |
2.9% |
| Skin Lesion |
2.9% |
| Deep Vein Thrombosis |
1.4% |
| Disease Recurrence |
1.4% |
| Hypersensitivity |
1.4% |
| International Normalised Ratio |
1.4% |
| Limb Injury |
1.4% |
| Mitral Valve Replacement |
1.4% |
| Nausea |
1.4% |
| Onychomycosis |
1.4% |
| Pityriasis |
1.4% |
|
| International Normalised Ratio Increased |
43.2% |
| Anaphylactic Reaction |
5.4% |
| Pyrexia |
5.4% |
| Chemical Injury |
2.7% |
| Cleft Palate |
2.7% |
| Death Neonatal |
2.7% |
| Dermatitis Allergic |
2.7% |
| Drug Ineffective |
2.7% |
| Dysuria |
2.7% |
| Fungal Infection |
2.7% |
| Gastrointestinal Haemorrhage |
2.7% |
| Malaise |
2.7% |
| Maternal Drugs Affecting Foetus |
2.7% |
| Maternal Exposure During Pregnancy |
2.7% |
| No Therapeutic Response |
2.7% |
| Product Substitution Issue |
2.7% |
| Pruritus |
2.7% |
| Rash Pruritic |
2.7% |
| Rash Pustular |
2.7% |
| Tongue Haematoma |
2.7% |
|
| Secondary |
| Product Used For Unknown Indication |
41.8% |
| Drug Use For Unknown Indication |
23.3% |
| Drug Exposure During Pregnancy |
12.0% |
| Hypertension |
7.1% |
| Maternal Exposure During Pregnancy |
2.7% |
| Muscle Spasms |
2.4% |
| Pyrexia |
1.8% |
| Leukaemia |
1.3% |
| Fungal Infection |
1.1% |
| Pseudomonas Infection |
1.1% |
| Skin Candida |
0.9% |
| Infection |
0.7% |
| Pain |
0.7% |
| Stress |
0.7% |
| Dermatitis |
0.4% |
| Erythema |
0.4% |
| Hypersensitivity |
0.4% |
| Migraine |
0.4% |
| Multiple Allergies |
0.4% |
| Accidental Poisoning |
0.2% |
|
| Vestibular Disorder |
28.2% |
| International Normalised Ratio Increased |
10.3% |
| Premature Baby |
10.3% |
| Bone Marrow Failure |
5.1% |
| Hepatitis Cholestatic |
5.1% |
| Staphylococcal Infection |
5.1% |
| Cheilitis |
2.6% |
| Drug Exposure During Pregnancy |
2.6% |
| Drug Ineffective |
2.6% |
| Dysuria |
2.6% |
| Erythema |
2.6% |
| Femoral Neck Fracture |
2.6% |
| Foetal Arrhythmia |
2.6% |
| Foetal Exposure During Delivery |
2.6% |
| Hip Dysplasia |
2.6% |
| Maternal Drugs Affecting Foetus |
2.6% |
| Periventricular Leukomalacia |
2.6% |
| Pyrexia |
2.6% |
| Stridor |
2.6% |
| Type Iv Hypersensitivity Reaction |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
26.1% |
| Product Used For Unknown Indication |
16.4% |
| Hiv Infection |
7.7% |
| Renal Transplant |
5.1% |
| Hypertension |
4.1% |
| Parkinson's Disease |
4.0% |
| Pain |
3.8% |
| Nutritional Supplementation |
3.7% |
| Rheumatoid Arthritis |
3.5% |
| Atrial Fibrillation |
3.4% |
| Fungal Infection |
2.8% |
| Chest Pain |
2.6% |
| Neuralgia |
2.5% |
| Hypercalcaemia Of Malignancy |
2.3% |
| Non-small Cell Lung Cancer |
2.3% |
| Insomnia |
2.2% |
| Diarrhoea |
2.0% |
| Back Pain |
1.8% |
| Depression |
1.8% |
| Oral Contraception |
1.8% |
|
| Weight Decreased |
21.2% |
| Vomiting |
9.1% |
| Pneumonia |
8.1% |
| Pain |
6.1% |
| Hyponatraemia |
5.1% |
| Dyspnoea |
4.0% |
| International Normalised Ratio Increased |
4.0% |
| Meningoradiculitis |
4.0% |
| Platelet Count Decreased |
4.0% |
| Pneumonia Aspiration |
4.0% |
| Pruritus |
4.0% |
| Type 2 Diabetes Mellitus |
4.0% |
| Asthenia |
3.0% |
| Staphylococcal Infection |
3.0% |
| Tooth Extraction |
3.0% |
| Upper Respiratory Tract Infection |
3.0% |
| Ventricular Fibrillation |
3.0% |
| Wheezing |
3.0% |
| Anastomotic Haemorrhage |
2.0% |
| Cholestasis |
2.0% |
|
| Interacting |
| Bronchitis |
50.0% |
| Fungal Infection |
25.0% |
| International Normalised Ratio |
25.0% |
|
| Malaise |
33.3% |
| Pneumonia |
33.3% |
| Rectal Haemorrhage |
33.3% |
|
